Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17beta-estradiol | increases expression | ISO | STK26 (Homo sapiens) | 6480464 | Estradiol results in increased expression of STK26 mRNA | CTD | PMID:16514628 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | STK26 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:31675489 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of STK26 mRNA | CTD | PMID:32109520 more ... | 3,3',5,5'-tetrabromobisphenol A | increases expression | ISO | STK26 (Homo sapiens) | 6480464 | tetrabromobisphenol A results in increased expression of STK26 protein | CTD | PMID:31675489 | 4,4'-sulfonyldiphenol | increases expression | ISO | Stk26 (Mus musculus) | 6480464 | bisphenol S results in increased expression of STK26 mRNA | CTD | PMID:30951980 | 4-hydroxyphenyl retinamide | increases expression | ISO | Stk26 (Mus musculus) | 6480464 | Fenretinide results in increased expression of STK26 mRNA | CTD | PMID:28973697 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of STK26 mRNA | CTD | PMID:28959563 | afimoxifene | decreases expression | ISO | STK26 (Homo sapiens) | 6480464 | afimoxifene results in decreased expression of STK26 mRNA | CTD | PMID:16514628 | all-trans-retinoic acid | decreases expression | ISO | STK26 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of STK26 mRNA | CTD | PMID:33167477 | antirheumatic drug | decreases expression | ISO | STK26 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of STK26 mRNA | CTD | PMID:24449571 | benzo[a]pyrene | affects methylation | ISO | STK26 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of STK26 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | STK26 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of STK26 promoter | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | STK26 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20018196 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of STK26 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | STK26 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of STK26 protein | CTD | PMID:31675489 | bisphenol A | increases expression | ISO | Stk26 (Mus musculus) | 6480464 | bisphenol A results in increased expression of STK26 mRNA | CTD | PMID:30951980 and PMID:32156529 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of STK26 gene | CTD | PMID:28505145 | bisphenol F | increases expression | ISO | Stk26 (Mus musculus) | 6480464 | bisphenol F results in increased expression of STK26 mRNA | CTD | PMID:30951980 | cadmium atom | decreases expression | ISO | STK26 (Homo sapiens) | 6480464 | Cadmium results in decreased expression of STK26 mRNA | CTD | PMID:24376830 | cadmium sulfate | multiple interactions | ISO | STK26 (Homo sapiens) | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of STK26 mRNA | CTD | PMID:18654764 | calcitriol | increases expression | ISO | STK26 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of STK26 mRNA | CTD | PMID:26485663 | cannabidiol | multiple interactions | ISO | STK26 (Homo sapiens) | 6480464 | [Cuprizone co-treated with Cannabidiol] results in decreased expression of STK26 protein | CTD | PMID:34122009 | carbamazepine | affects expression | ISO | STK26 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of STK26 mRNA | CTD | PMID:25979313 | chlordecone | multiple interactions | ISO | Stk26 (Mus musculus) | 6480464 | Chlordecone promotes the reaction [Biomarkers metabolite binds to STK26 gene] | CTD | PMID:31084621 | chlormequat chloride | increases expression | EXP | | 6480464 | Chlormequat results in increased expression of STK26 protein | CTD | PMID:34958886 | chromium atom | increases expression | ISO | STK26 (Homo sapiens) | 6480464 | Chromium results in increased expression of STK26 mRNA | CTD | PMID:21437242 | cobalt dichloride | multiple interactions | ISO | STK26 (Homo sapiens) | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of STK26 mRNA | CTD | PMID:18654764 | cobalt dichloride | decreases expression | ISO | STK26 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of STK26 mRNA | CTD | PMID:19320972 | copper(II) sulfate | decreases expression | ISO | STK26 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of STK26 mRNA | CTD | PMID:19549813 | coumarin | increases phosphorylation | ISO | STK26 (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of STK26 protein | CTD | PMID:35688186 | Cuprizon | multiple interactions | ISO | STK26 (Homo sapiens) | 6480464 | [Cuprizone co-treated with Cannabidiol] results in decreased expression of STK26 protein | CTD | PMID:34122009 | cyclosporin A | decreases expression | ISO | STK26 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of STK26 mRNA | CTD | PMID:27989131 | dorsomorphin | multiple interactions | ISO | STK26 (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STK26 mRNA | CTD | PMID:27188386 | doxorubicin | affects response to substance | ISO | STK26 (Homo sapiens) | 6480464 | STK26 protein affects the susceptibility to Doxorubicin | CTD | PMID:16217747 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of STK26 mRNA | CTD | PMID:29391264 | FR900359 | increases phosphorylation | ISO | STK26 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of STK26 protein | CTD | PMID:37730182 | fulvestrant | decreases expression | ISO | STK26 (Homo sapiens) | 6480464 | fulvestrant results in decreased expression of STK26 mRNA | CTD | PMID:16514628 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of STK26 mRNA | CTD | PMID:33387578 | glycidyl methacrylate | decreases expression | ISO | STK26 (Homo sapiens) | 6480464 | glycidyl methacrylate results in decreased expression of STK26 protein | CTD | PMID:36641056 | gold atom | decreases expression | ISO | STK26 (Homo sapiens) | 6480464 | Gold results in decreased expression of STK26 mRNA | CTD | PMID:25523186 | gold(0) | decreases expression | ISO | STK26 (Homo sapiens) | 6480464 | Gold results in decreased expression of STK26 mRNA | CTD | PMID:25523186 | isobutanol | multiple interactions | ISO | STK26 (Homo sapiens) | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of STK26 mRNA | CTD | PMID:29432896 | ivermectin | decreases expression | ISO | STK26 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of STK26 protein | CTD | PMID:32959892 | lead(II) chloride | multiple interactions | ISO | STK26 (Homo sapiens) | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of STK26 mRNA | CTD | PMID:18654764 | lipopolysaccharide | multiple interactions | ISO | STK26 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of STK26 mRNA | CTD | PMID:35811015 | lipopolysaccharide | increases expression | ISO | STK26 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of STK26 mRNA | CTD | PMID:35811015 | methylmercury chloride | multiple interactions | ISO | STK26 (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STK26 mRNA | CTD | PMID:27188386 | methylmercury chloride | increases expression | ISO | STK26 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of STK26 mRNA | CTD | PMID:26272509 | monosodium L-glutamate | increases expression | ISO | Stk26 (Mus musculus) | 6480464 | Sodium Glutamate results in increased expression of STK26 mRNA | CTD | PMID:22078008 | monosodium L-glutamate | multiple interactions | ISO | Stk26 (Mus musculus) | 6480464 | [Trans Fatty Acids co-treated with Sodium Glutamate] results in decreased expression of STK26 mRNA | CTD | PMID:22078008 | paracetamol | increases expression | ISO | STK26 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of STK26 mRNA | CTD | PMID:21420995 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of STK26 mRNA | CTD | PMID:33387578 | quercetin | decreases expression | ISO | STK26 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of STK26 mRNA | CTD | PMID:21632981 | quercetin | decreases phosphorylation | ISO | STK26 (Homo sapiens) | 6480464 | Quercetin results in decreased phosphorylation of STK26 protein | CTD | PMID:35688186 | raloxifene | decreases expression | ISO | STK26 (Homo sapiens) | 6480464 | Raloxifene Hydrochloride results in decreased expression of STK26 mRNA | CTD | PMID:16514628 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | STK26 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of STK26 mRNA | CTD | PMID:35811015 | SB 431542 | multiple interactions | ISO | STK26 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 and PMID:37664457 | sodium tungstate | increases expression | ISO | STK26 (Homo sapiens) | 6480464 | sodium tungstate(VI) results in increased expression of STK26 mRNA | CTD | PMID:26164860 | succimer | multiple interactions | ISO | Stk26 (Mus musculus) | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of STK26 mRNA | CTD | PMID:26378955 | sunitinib | decreases expression | ISO | STK26 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of STK26 mRNA | CTD | PMID:31533062 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of STK26 mRNA | CTD | PMID:33387578 | triclosan | increases expression | ISO | STK26 (Homo sapiens) | 6480464 | Triclosan results in increased expression of STK26 mRNA | CTD | PMID:30510588 | tris(2-butoxyethyl) phosphate | affects expression | ISO | STK26 (Homo sapiens) | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of STK26 mRNA | CTD | PMID:29024780 | valproic acid | increases methylation | ISO | STK26 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of STK26 gene | CTD | PMID:29154799 | vincaleukoblastine | affects response to substance | ISO | STK26 (Homo sapiens) | 6480464 | STK26 protein affects the susceptibility to Vinblastine | CTD | PMID:16217747 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of STK26 mRNA | CTD | PMID:23034163 | vorinostat | increases expression | ISO | STK26 (Homo sapiens) | 6480464 | vorinostat results in increased expression of STK26 mRNA | CTD | PMID:27188386 | zinc atom | decreases expression | ISO | STK26 (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of STK26 mRNA | CTD | PMID:22171008 | zinc(0) | decreases expression | ISO | STK26 (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of STK26 mRNA | CTD | PMID:22171008 | |